Your AI-Trained Oncology Knowledge Connection!
Video
Author(s):
Mark D. Duncan, MD, from The Johns Hopkins University School of Medicine, discusses demonstrable metrics that help measure the success of a patient navigation program.
Mark D. Duncan, MD, Vice Chair and Associate Professor of Surgery and Oncology, The Johns Hopkins University School of Medicine, discusses demonstrable metrics that help measure the success of a patient navigation program.
Duncan explains that it is very difficult to measure the success of a navigation program based solely on improvements in survival or cure rates. The more demonstrable metrics to measure are those showing improved care, such as pain management scores, comfort, and the timeliness of care.
Since navigators fulfill a series of tasks across the entire cancer care continuum, their efficacy can also be measured through patient education, outreach, screening, diagnosis, staging, treatment, survivorship, and end-of-life care. It has been shown that patient navigator programs can increase both access and utilization of care for poor and underserved individuals. This outreach results in higher cancer screening rates, Duncan notes, which can be measured easily.
May 1st 2025 - May 2nd 2026
Apr 30th 2025 - May 1st 2026
Apr 30th 2025 - May 1st 2026
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
Apr 30th 2025 - May 1st 2026
Apr 30th 2025 - May 1st 2026
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
Apr 30th 2025 - May 1st 2026
Apr 30th 2025 - May 1st 2026
Insights From Liso-cel Combined With Ibr for R/RCLL/SLL: Primary Results From the Open-Label, Phase 1/2 Transcend CLL 004 Study
Overview of the Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients With Previously Untreated DLBCL Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
Ultra-Low PSA Response With Darolutamide/ADT Correlates With Better Outcomes in mHSPC
Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC
2 Commerce Drive
Cranbury, NJ 08512